Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02863029 · ClinicalTrials.gov registry record · NA
Defining the Role of the Gut Microbiome in Mediating the Effects of Obesity on Intestinal Stem Cells
A NA study, sponsored by Mayo Clinic.
- Terminated
- Registry status
- NA
- Development phase
- 4
- Enrollment target
NCT02863029: Clinical Trial NA study, sponsored by Mayo Clinic.
NCT02863029 is a NA study that was terminated before completion, run by Mayo Clinic. The registered enrollment target is 4 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02863029, a NA study, was terminated before completion, sponsored by Mayo Clinic.
- TERMINATED
- Registry status
- NA
- Development phase
- 4 participants
- Enrollment target
Study Summary
New studies are revealing how a high-fat diet could be making the cells of the intestinal lining more likely to become cancerous. The investigators would like to study how obesity influences growth of intestinal stem cells, which could then trigger intestinal tumors. The investigators are proposing a Pilot Study of 20 subjects (comprised of 10 participants from each of two different BMI categories: 20-25 and 35 \& above), who will be asked to provide blood, stool, \& urine samples, undergo a flexible sigmoidoscopy, and complete food frequency questionnaires
Primary Outcome
The gut microbiome is altered in obesity and studying intestinal stem cells will be helpful in learning what triggers intestinal tumors.
Interventions
- PROCEDURE Flexible Sigmoidoscopy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2017-01 |
| Est. Completion | 2017-03-09 |
| Phase | NA |
Why NCT02863029 stopped before completion
NCT02863029 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 4 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which Flexible Sigmoidoscopy is the first listed.
NCT02863029 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02863029 about?
NCT02863029 is a clinical study titled "Defining the Role of the Gut Microbiome in Mediating the Effects of Obesity on Intestinal Stem Cells". New studies are revealing how a high-fat diet could be making the cells of the intestinal lining more likely to become cancerous. The investigators would like to study how obesity influences growth of intestinal stem cells, which could then trigger intestinal tumors. The investigators are proposing...
What is the current status of trial NCT02863029?
This trial is currently terminated. It is a NA study. The enrollment target is 4 participants. The study started on 2017-01. Estimated completion is 2017-03-09.
What interventions are being tested in trial NCT02863029?
The interventions under investigation include: Flexible Sigmoidoscopy (PROCEDURE).
Who is sponsoring clinical trial NCT02863029?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02863029's enrollment target sits among peer trials
4 1996th of 2000 higher than 5 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia